Nuvation Bio NUVB Warrants and Rights Outstanding
Warrants and Rights Outstanding at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nuvation Bio's warrants and rights outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nuvation Bio's warrants and rights outstanding?
- Nuvation Bio (NUVB) reported warrants and rights outstanding of 5.8M in Q4 2025.
- How has Nuvation Bio's warrants and rights outstanding changed year-over-year?
- Nuvation Bio's warrants and rights outstanding decreased by 0.0% year-over-year, from 5.8M to 5.8M.
- What is the long-term trend for Nuvation Bio's warrants and rights outstanding?
- Over 4 years (2021 to 2025), Nuvation Bio's warrants and rights outstanding has grown at a 0.0% compound annual growth rate (CAGR), from 5.8M to 5.8M.
- What does warrants and rights outstanding mean?
- This represents the total number or aggregate value of warrants and rights currently held by third parties that grant the holder the option to purchase company shares. It is a critical metric for calculating fully diluted share counts and assessing potential future equity dilution. Investors monitor this to understand the impact of potential share issuance on existing shareholder value.